GlassScriptPhysician profile
Raghav Gattani
NPI 1457871808
$12,364.85
in general payments reported to CMS, 2019-2025
17 companies · $3,092 in 2025
The $3,092 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $584 · 2022: $647 · 2023: $1,559 · 2024: $6,483 · 2025: $3,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,769 · Food and Beverage: $5,170 · Education: $165 · Honoraria: $28.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,769.41 |
| Food and Beverage | $5,170.13 |
| Education | $165.28 |
| Honoraria | $28.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,831.78 | 2021-2025 | Mitraclip, Optis, Ultreon |
| Medtronic, INC. | $3,667.36 | 2021-2025 | Corevalve Evolut R, Onyx Frontier |
| Edwards Lifesciences Corporation | $2,318.69 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $635.19 | 2023-2025 | Avvigo Guidance System, Sentinel |
| Abiomed | $484.56 | 2023-2025 | Impella |
| Cardiovascular Systems INC. | $412.54 | 2021-2022 | |
| Asahi Intecc USA, INC. | $318.88 | 2025 | Asahi Coronary Wires |
| Amgen INC. | $180.46 | 2023-2025 | Repatha, Repatha |
| Inari Medical, INC. | $170.60 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Teleflex LLC | $120.65 | 2024-2025 | Turnpike, Micro Elite |
| Penumbra, INC. | $63.06 | 2023 | Indigo System |
| Getinge USA Sales, LLC | $49.64 | 2022 | |
| Terumo Medical Corporation | $28.66 | 2025 | Metacross Otw, Glidewire |
| Recor Medical INC | $26.52 | 2025 | Paradise Ultrasound Renal Denervation System |
| Alnylam Pharmaceuticals INC. | $25.00 | 2025 | Onpattro |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.23 | 2025 | Jardiance |
| Chiesi USA, INC. | $13.03 | 2023 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raghav Gattani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.